ASCO Soundbites, vol. 3: Real-time approvals, Pfizer's second rodeo and 'the busiest ASCO ever'

With ASCO nearing its official close, it's time to round up our favorite quotes from the weekend—a process that's become somewhat of a tradition for us over the last couple of years. Read on to see the most colorful things pharma execs had to say about the conference, their data, the FDA, genetic testing, and everything in between.